XML 51 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
BUSINESS COMBINATION (Details Textual) - USD ($)
$ in Thousands
2 Months Ended 3 Months Ended 9 Months Ended
Aug. 06, 2018
Sep. 30, 2018
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenues     $ 50,703 $ 48,164 $ 144,454 $ 129,556
Net Income (Loss) Attributable to Parent     5,037 4,720 10,064 8,553
Business Acquisition, Pro Forma Net Income (Loss)     $ 4,456 $ 8,683 [1] $ 7,812 $ 10,108 [1]
WellSpring Pharma Services Inc [Member]            
Business Combination, Consideration Transferred $ 17,300          
Revenues   $ 1,700        
Net Income (Loss) Attributable to Parent   $ (200)        
Business Acquisition Pro Forma Information Effective Tax Rate         23.00% 37.00%
Business Combination, Acquisition Related Costs         $ 1,000  
Business Combination Purchase Price Before Adjustments $ 18,000          
[1] Net income for the three and nine months ended September 30, 2017 includes the impact to WellSpring of $4.4 million of related party debt forgiveness.